RD Gelber

5.3k citations

35 papers · 1.6k indexed · h-index 14

Impact in

Cancer Research top 5%
- Breast Cancer Treatment Studies
Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation

Papers in

Cancer Research 17
- Breast Cancer Treatment Studies 14
Hematology 8
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 4

Co-authors: Aron Goldhirsch Monica Castiglione‐Gertsch Alan Nevill R. J. Cote B.A. Gusterson Benjaporn Chaiwun S. E. Sallan C. Norman Coleman
Journals: Cancer Research (11 papers)Journal of Clinical Oncology (9 papers)Blood (6 papers)International Journal of Gynecology & Obstetrics (1 paper)The Lancet (1 paper)
Partner nations: United States Belgium Switzerland

In The Last Decade

RD Gelber

34 papers receiving 1.5k citations

Peers

Countries citing papers authored by RD Gelber

Since Specialization

Citations

This map shows the geographic impact of RD Gelber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RD Gelber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RD Gelber more than expected).

Fields of papers citing papers by RD Gelber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RD Gelber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RD Gelber. The network helps show where RD Gelber may publish in the future.

Co-authors

The 25 scholars most cited alongside RD Gelber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with RD Gelber Line = papers co-authored together RD Gelber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract PD1-03: Cholesterol, cholesterol lowering medication use, and breast cancer outcomes in the BIG 1-98 study Cancer Research ·Signe Borgquist, Anita Giobbie‐Hurder, Thomas P. Ahern, 李海水, Marco Colleoni, Marcelo Moras Goulart, M. Debled, Bent Ejlertsen, Sara Jelvegård, A. Goldhirsch, K.N. Price, RD Gelber, MM Regan, B. Thürlimann	2016	2
2	Abstract S3-2: Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: The CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02) Cancer Research ·Stefan Aebi, Shari Gelber, István Láng, María Eugenia Villarreal, A. Robidoux, Marina Gracinda Modesto, 玉军张, EP Mamounas, CE Geyer, Rudolf Maibach, RD Gelber, Norman Wolmark, Irene Wapnir	2012	10
3	Abstract S1-1: Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial. Cancer Research ·Otto Metzger, Anita Giobbie‐Hurder, Elizabeth Mallon, Abinaya Elango, Frédéric Smeets, Beat Thürlimann, RD Gelber, Marco Colleoni, Bent Ejlertsen, 吕秀娥, Sara Jelvegård, A. Goldhirsch, B.A. Gusterson, (unknown), (unknown)	2012	6
4	Abstract P6-07-06: Patterns of locoregional failure in the CALOR (Chemotheraphy as Adjuvant for Locally Recurrent Breast Cancer) Trial Cancer Research ·Ummul Khair Asema, Françoise Carton de Tournai, István Láng, María Eugenia Villarreal, Ludington Lg, Michael Martin, 玉军张, EP Mamounas, CE Geyer, वेङ्कटीश ढकाल, RD Gelber, Norman Wolmark, Stefan Aebi	2012	1
5	Abstract P4-09-12: The Effect of Age on Breast Cancer Outcomes in Women with Her-2 Positive Breast Cancer: Results from the HERA Trial Cancer Research ·AH Partridge, JiuSheng PENG, Martine Piccart, Neal Watkins, Nicolas Barber, EP Winer, RD Gelber	2010	3
6	Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from trial BIG 1-98 comparing adjuvant endocrine therapy with tamoxifen versus letrozole Journal of Clinical Oncology ·Abinaya Elango, Anita Giobbie‐Hurder, MM Regan, Sara Jelvegård, AW Sinkfield, Patrizia Dell’Orto, Eugenio Maiorano, Gaëtan MacGrogan, Stephen Braye, Estefany Lorena Brochero Muñoz, Patrick Neven, Zsolt Orosz, Elisa L Russo, Fiona Knox, B. Thürlimann, K.N. Price, Monica Castiglione‐Gertsch, RD Gelber, B A Gusterson, Aron Goldhirsch	2008	3
7	Predictors of early recurrence in postmenopausal women with hormone receptor positive breast cancer in the BIG 1-98 trial European Journal of Cancer Supplements ·L. Mauriac, Aparna Keshaviah, M. Debled, H.T. Mouridsen, JF Forbes, 屠一帆, Robert Paridaens, RD Gelber, Monica Castiglione‐Gertsch, Aron Goldhirsch	2006	10
8	Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995) Leukemia ·Hu Xiyun, Lieven Declerck, RD Gelber, T. Hayashi, Brian Heiner, RD Barr, LA Clavell, CA Hurwitz, Albert Moghrabi, Yves Samson, Yu. G. Likhachev, Lipton Jm, HJ Cohen, SE Sallan	2000	121
9	Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children Shin Nakamura, RD Gelber, S. Blattner, S. E. Sallan, Stephen J. Chanock	2000	5
10	Role of immunohistochemical detection of lymph-node metastases in management of breast cancer The Lancet ·R. J. Cote, Pega Sanoamuang, Benjaporn Chaiwun, RD Gelber, Aron Goldhirsch, Monica Castiglione‐Gertsch, B.A. Gusterson, Alan Nevill	1999	405
11	Second malignancies in patients treated for childhood acute lymphoblastic leukemia. Journal of Clinical Oncology ·T. Hayashi, RD Gelber, I. Morokhov, Olsvig-Whittaker Linda, N.J. Tarbell, S. E. Sallan	1998	81
12	Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia Blood ·N Paoletti, Ellen Kornmehl, NJ Tarbell, O.V. Pravoslavnaya, RD Gelber, Jerome Ritz, SE Sallan	1993	2
13	The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology ·Deborah P. Waber, N J Tarbell, Cláudio Bacal, RD Gelber, S. E. Sallan	1992	113
14	Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols Annals of Oncology ·C. Niemeyer, Alfred Reiter, H. Riehm, M Donnelly, RD Gelber, S. E. Sallan	1991	37
15	Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update) Blood ·CM Niemeyer, RD Gelber, NJ Tarbell, M Donnelly, LA Clavell, Letícia P. S. Isidoro, Jian-Teng Lin, HJ Cohen, SE Sallan	1991	64
16	Improved methodology for analyzing local and distant recurrence. Journal of Clinical Oncology ·Rebecca Gelman, RD Gelber, I. Craig Henderson, C. Norman Coleman, Jay R. Harris	1990	190
17	Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. Journal of Clinical Oncology ·Gregory D. Longmore, EC Guinan, Howard J. Weinstein, RD Gelber, Joel M. Rappeport, Joseph H. Antin	1990	70
18	Autologous bone marrow transplantation for acute lymphoblastic leukemia. Journal of Clinical Oncology ·Stephen E. Sallan, Charlotte M. Niemeyer, Amy L. Billett, Jeffrey M. Lipton, N.J. Tarbell, RD Gelber, Christine Murray, Sandra Maíra de Souza, O. Miazina, Robert C. Bast	1989	69
19	Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia Blood ·Keith Simfukwe, VM Kimball, H Elis, M Donnelly, K Pavelka, RD Gelber, Ramana Tantravahi, SE Sallan	1989	7
20	Designing and Analyzing Clinical Trials Which Allow Institutions to Randomize Patients to a Subset of the Treatments under Study Biometrics ·David Schoenfeld, RD Gelber	1979	8

About RD Gelber

RD Gelber is a scholar working on Cancer Research, Hematology, Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Acute Lymphoblastic Leukemia research (12 papers), Advanced Breast Cancer Therapies (9 papers), Estrogen and related hormone effects (9 papers), Cancer Treatment and Pharmacology (5 papers), Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (484 citations), Hematology (355 citations), Pathology and Forensic Medicine (343 citations), Oncology (485 citations) and Public Health, Environmental and Occupational Health (487 citations). RD Gelber has collaborated with scholars based in United States, Belgium and Switzerland. Frequent co-authors include Aron Goldhirsch, Monica Castiglione‐Gertsch, Alan Nevill, R. J. Cote, B.A. Gusterson, Benjaporn Chaiwun, S. E. Sallan, C. Norman Coleman, I. Craig Henderson and Jay R. Harris. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Blood, International Journal of Gynecology & Obstetrics and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact